Clinical Trial Update: Sorafenib Versus Best Supportive Care in Egyptian Hepatocellular Carcinoma Patients. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing sorafenib with best supportive care in Egyptian patients with hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Ain Shams University | Conditions: HCC | Phase 3 | Status: COMPLETED